BELLUS HEALTH

#3569 COMPANY RANKING
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.
ninja emoji
73 emps
light emoji
Since 2010
money emoji
Worth 2B

Bellus Health's Related Companies

Explore a rich selection of stories about your favorite games, how they are made, and the people that make them, from gamers and game developers worldwide.

Representing this company? Click here to claim and customize this page!

Reviews About Bellus Health

avatar

Bellus Health WIKI

Apply to get your Tech Company News Page live on HackerNoon.com today!